Outcome MeasureOther

WAI-SR

Working Alliance Inventory – Short Revised

2 Papers in Blossom

Clinical Thresholds

1260
Poor alliance
Score 12–30
Moderate alliance
Score 31–45
Strong alliance
Score 46–60

Outcome Data Across Studies

Reported results for WAI-SR across 2 studies with quantitative data.

Outcome data across 5 study arm–timepoint observations
SD
Preliminary evidence for the importance of therapeutic alliance in MDMA-assisted psychotherapy for posttraumatic stress disorder
2024Exploratory
MDMA-AT(experimental)0226.20.7—
Preliminary evidence for the importance of therapeutic alliance in MDMA-assisted psychotherapy for posttraumatic stress disorder
2024Exploratory
MDMA-AT(experimental)7226.30.6—
Preliminary evidence for the importance of therapeutic alliance in MDMA-assisted psychotherapy for posttraumatic stress disorder
2024Exploratory
MDMA-AT(experimental)14226.30.6—
The therapeutic alliance between study participants and intervention facilitators is associated with acute effects and clinical outcomes in a psilocybin-assisted therapy trial for major depressive disorder
2024Secondary
Immediate Treatment(experimental)02050.86.5—
The therapeutic alliance between study participants and intervention facilitators is associated with acute effects and clinical outcomes in a psilocybin-assisted therapy trial for major depressive disorder
2024Secondary
Immediate Treatment(experimental)72054.38.30.001

Papers Using WAI-SR

Open Accessindividual

The therapeutic alliance between study participants and intervention facilitators is associated with acute effects and clinical outcomes in a psilocybin-assisted therapy trial for major depressive disorder

In a randomised, waiting‑list‑controlled psilocybin‑assisted therapy trial for major depressive disorder (N = 24), therapeutic alliance strengthened over time and higher alliance ratings before and shortly after dosing predicted stronger acute mystical and psychological‑insight experiences and significantly greater reductions in depressive symptoms up to 12 months. These results highlight the therapeutic relationship as an important predictor of both acute psychedelic experiences and long‑term clinical outcomes.

Published
Journal
PLOS ONE
Authors
Levin, A. W., Lancelotta, R., Sepeda, N. D., Gukasyan, N., Nayak, S., Wagener, T. L., Barrett, F. S., Griffiths, R. R., Davis, A. K.
Open Accessindividual

Preliminary evidence for the importance of therapeutic alliance in MDMA-assisted psychotherapy for posttraumatic stress disorder

This analysis of a clinical trial (n=22) examines the role of therapeutic alliance in MDMA-assisted psychotherapy (MDMA-AP) for treating chronic PTSD. It reports that after controlling for baseline PTSD severity, a strong therapeutic alliance at the mid and late stages of treatment (sessions 4 and 9) significantly predicts lower clinician-assessed and self-reported PTSD severity post-treatment.

Published
Journal
European Journal of Psychotraumatology
Authors
Zeifman, R. J., Kettner, H., Ross, S., Weiss, B., Mithoefer, M. C., Mithoefer, A. T., Wagner, A. C.

Quick Facts

Full Name
Working Alliance Inventory – Short Revised
Domain
Other
Papers Indexed
2
Score Range
12–60
Interpretation
Higher = better
Unit
points
All Measures